Background Xpert MTB/RIF (Xpert MTB/RIF) and Xpert MTB/RIF Ultra (Xpert Ultra), the
newest version, are the only World Health Organization (WHO)‐recommended rapid tests …

Background Accurate and rapid detection of tuberculosis (TB) and drug resistance are
critical for improving patient care and decreasing the spread of TB. Xpert® MTB/RIF assay …

Rapid progress has been made in the development of new diagnostic assays for
tuberculosis in recent years. New technologies have been developed and assessed, and …

The current methods available to diagnose antimicrobial-resistant Mycobacterium
tuberculosis infections require a positive culture or only test a limited number of resistance …

Tuberculous meningitis (TBM) is the most severe form of tuberculosis. Microbiological
confirmation is rare, and treatment is often delayed, increasing mortality and morbidity. The …

Background Rapid molecular diagnostics for detecting multidrug-resistant and extensively
drug-resistant tuberculosis (M/XDR-TB) primarily identify mutations in Mycobacterium …

OBJECTIVES: Xpert MTB/RIF (Cepheid) assay has been introduced for the diagnosis of
tuberculosis (TB) and RIF-resistance. The meta-analysis was used to establish the overall …

Background Xpert MTB/RIF and Xpert MTB/RIF Ultra (Xpert Ultra) are World Health
Organization (WHO)‐recommended rapid tests that simultaneously detect tuberculosis and …

Background The Xpert MTB/RIF test enables rapid detection of tuberculosis (TB) and
rifampicin resistance. The World Health Organization recommends Xpert for initial diagnosis …

Respiratory tract infections rank second as causes of adult and paediatric morbidity and
mortality worldwide. Respiratory tract infections are caused by many different bacteria …